A Phase 1, Multicenter Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
Latest Information Update: 04 Oct 2024
At a glance
- Drugs SCG 101 (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Sponsors SCG Cell Therapy
- 04 Oct 2024 New trial record